June 20, 2024
Three-dimensional telomere profiling predicts risk of progression in smoldering multiple myeloma
To date, identifying high-risk SMM patients remains an important clinical need. In this study, we present the 3-dimensional telomere profiling as a structural biomarker capable of stratifying SMM patients as a function of genomic instability